Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Miskovsky

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cellular Immunology|February 13, 2001
Crosslinking CD81 results in activation of TCRgammadelta T cellsC T Tseng, E Miskovsky, G R Klimpel
Hepatology (Baltimore, Md.)|May 9, 2001
Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infectionsC T Tseng, E Miskovsky, M Houghton, et al.
The American Journal of Gastroenterology|October 1, 1994
Thrombin injection for bleeding duodenal varicesR Rai, S W Panzer, E Miskovsky, et al.
Hepatology (Baltimore, Md.)|June 8, 2001
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infectionS E Bassett, B Guerra, K Brasky, et al.
Vaccine|May 1, 1991
Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigensE Miskovsky, K Gershman, M L Clements, et al.
The Journal of Infectious Diseases|September 1, 1994
Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigensM L Clements, E Miskovsky, M Davidson, et al.
Journal of Viral Hepatitis|June 26, 2003
A rapid immunochromatographic assay for hepatitis B virus screeningD T-Y Lau, H Ma, S M Lemon, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cellular Immunology|February 13, 2001
Crosslinking CD81 results in activation of TCRgammadelta T cellsC T Tseng, E Miskovsky, G R Klimpel
Hepatology (Baltimore, Md.)|May 9, 2001
Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infectionsC T Tseng, E Miskovsky, M Houghton, et al.
The American Journal of Gastroenterology|October 1, 1994
Thrombin injection for bleeding duodenal varicesR Rai, S W Panzer, E Miskovsky, et al.
Hepatology (Baltimore, Md.)|June 8, 2001
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infectionS E Bassett, B Guerra, K Brasky, et al.
Vaccine|May 1, 1991
Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigensE Miskovsky, K Gershman, M L Clements, et al.
The Journal of Infectious Diseases|September 1, 1994
Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigensM L Clements, E Miskovsky, M Davidson, et al.
Journal of Viral Hepatitis|June 26, 2003
A rapid immunochromatographic assay for hepatitis B virus screeningD T-Y Lau, H Ma, S M Lemon, et al.
Pageof 1